Serum thioredoxin reductase levels increase in response to chemically induced acute liver injury

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 7, 2014, Pages 2105-2111

  Sun, Kang ^a   Eriksson, Sofi E ^b   Tan, Yanping ^a   Zhang, Le ^a   Arnér, Elias S J ^b   Zhang, Jinsong ^a  

^a ANHUI AGRICULTURAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alanine aminotransferase; Hepatotoxicity; Serum; Thioredoxin reductase

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBON TETRACHLORIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SELENIUM; SUPEROXIDE DISMUTASE; THIOACETAMIDE; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME KINETICS; ENZYME MECHANISM; IMMUNOBLOTTING; LD 50; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE AMINOTRANSFERASE; HEPATOTOXICITY; SERUM; THIOREDOXIN REDUCTASE;

ANIMALS; ANTIOXIDANTS; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; THIOACETAMIDE; THIOREDOXIN REDUCTASE 1; THIOREDOXINS;

EID: 84900527790     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.02.028     Document Type: Article

References (53)

1. E.S. Arnér Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions Biochim. Biophys. Acta 1790 2009 495 526
2. E.S. Arnér, and A. Holmgren Measurement of thioredoxin and thioredoxin reductase M. Maines, L. Costa, D. Reed, S. Sassa, Current Protocols in Toxicology 2000 John Wiley & Sons, Inc. New York 7.4.1 7.4.14
3. S. Gromer, L.D. Arscott, C.H. Williams Jr., R.H. Schirmer, and K. Becker Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds J. Biol. Chem. 273 1998 20096 20101
4. K.E. Hill, G.W. McCollum, and R.F. Burk Determination of thioredoxin reductase activity in rat liver supernatant Anal. Biochem. 253 1997 123 125
5. A.D. Smith, C.A. Guidry, V.C. Morris, and O.A. Levander Aurothioglucose inhibits murine thioredoxin reductase activity in vivo J. Nutr. 129 1999 194 198
6. A.D. Smith, and O.A. Levander High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase Methods Enzymol. 347 2002 113 121
7. A. Holmgren, and M. Björnstedtm Thioredoxin and thioredoxin reductase Methods Enzymol. 252 1995 199 208
8. A. Söderberg, B. Sahaf, and A. Rosén Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma Cancer Res. 60 2000 2281 2289
9. C.A. Apffel, J.E. Walker, and I.T. Nathanson Tumor growth and disulfide reduction: possible dependence on protein-disulfide reductase J. Natl. Cancer Inst. 51 1973 575 583
10. A. Holmgren Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction J. Biol. Chem. 252 1977 4600 4606
11. J. Yodoi, and M. Maeda Discovery of ATL: an odyssey in restrospect Int. J. Hematol. 94 2011 423 428
12. T. Nakashima, Y. Sumida, T. Yoh, Y. Kakisaka, Y. Nakajima, H. Ishikawa, H. Mitsuyoshi, K. Kashima, H. Nakamura, and J. Yodoi Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid Antioxid. Redox Signal. 2 2000 687 694
13. Y. Sumida, T. Nakashima, T. Yoh, Y. Kakisaka, Y. Nakajima, H. Ishikawa, H. Mitsuyoshi, T. Okanoue, H. Nakamura, and J. Yodoi Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases Liver 21 2001 295 299
14. M. Luthman, and A. Holmgren Rat liver thioredoxin and thioredoxin reductase: purification and characterization Biochemistry 21 1982 6628 6633
15. J. Ozer, M. Ratner, M. Shaw, W. Bailey, and S. Schomaker The current state of serum biomarkers of hepatotoxicity Toxicology 245 2008 194 205
16. J.S. Ozer, R. Chetty, G. Kenna, J. Palandra, Y. Zhang, A. Lanevschi, N. Koppiker, B.E. Souberbielle, and S.K. Ramaiah Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury Regul. Toxicol. Pharmacol. 56 2010 237 246
17. J. Zhang, H. Wang, and H. Yu Thioacetamide-induced cirrhosis in selenium-adequate mice displays rapid and persistent abnormity of hepatic selenoenzymes which are mute to selenium supplementation Toxicol. Appl. Pharmacol. 224 2007 81 88
18. 4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis Arch. Toxicol. 2014 10.1007/s00204-013-1191-5
19. 4 exposure in mice Virchows Arch. 456 2010 423 431
20. A. Karmen, F. Wroblewski, and J.S. Ladue Transaminase activity in human blood J. Clin. Invest. 34 1955 126 131
21. I. Carlberg, and B. Mannervik Glutathione reductase Methods Enzymol. 113 1985 484 490
22. Y. Sun, L.W. Oberley, and Y. Li A simple method for clinical assay of superoxide dismutase Clin. Chem. 34 1988 497 500
23. X. Peng, J. Xu, and E.S. Arnér Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase Biochem. J. 447 2012 167 174
24. R.S. Mangipudy, S. Chanda, and H.M. Mehendale Tissue repair response as a function of dose in thioacetamide hepatotoxicity Environ. Health Perspect. 103 1995 260 267
25. J. Chilakapati, K. Shankar, M.C. Korrapati, R.A. Hill, and H.M. Mehendale Saturation toxicokinetics of thioacetamide: role in initiation of liver injury Drug Metab. Dispos. 33 2005 1877 1885
26. J. Chilakapati, M.C. Korrapati, R.A. Hill, A. Warbritton, J.R. Latendresse, and H.M. Mehendale Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide Toxicology 230 2007 105 116
27. A.L. Hunter, M.A. Holscher, and R.A. Neal Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system J. Pharmacol. Exp. Ther. 200 1977 439 448
28. R.O. Recknagel, E.A. Glende Jr., J.A. Dolak, and R.L. Waller Mechanisms of carbon tetrachloride toxicity Pharmacol. Ther. 43 1989 139 154
29. Y. Yoshikawa, T. Miyashita, S. Higuchi, K. Tsuneyama, S. Endo, T. Tsukui, Y. Toyoda, T. Fukami, M. Nakajima, and T. Yokoi Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries Toxicol. Appl. Pharmacol. 264 2012 42 50
30. J.R. Prigge, S. Eriksson, S.V. Iverson, T.A. Meade, M.R. Capecchi, E.S. Arnér, and E.E. Schmidt Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1 Free Radic. Biol. Med. 52 2012 803 810
31. M.P. Rigobello, M.T. Callegaro, E. Barzon, M. Benetti, and A. Bindoli Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability Free Radic. Biol. Med. 24 1998 370 376
32. H. Okuyama, H. Nakamura, Y. Shimahara, N. Uyama, Y.W. Kwon, N. Kawada, Y. Yamaoka, and J. Yodoi Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice J. Hepatol. 42 2005 117 123
33. K. Minami, R. Maniratanachote, M. Katoh, M. Nakajima, and T. Yokoi Simultaneous measurement of gene expression for hepatotoxicity in thioacetamide-administered rats by DNA microarrays Mutat. Res. 603 2006 64 73
34. 4-induced injury in liver by adenovirally introduced thioredoxin gene Biochem. Biophys. Res. Commun. 350 2006 157 161
35. K.J. Hintze, K.A. Wald, H. Zeng, E.H. Jeffery, and J.W. Finley Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element J. Nutr. 133 2003 2721 2727
36. E.S. Suvorova, O. Lucas, C.M. Weisend, M.F. Rollins, G.F. Merrill, M.R. Capecchi, and E.E. Schmidt Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes PLoS One 4 2009 e6158
37. S.V. Iverson, S. Eriksson, J. Xu, J.R. Prigge, E.A. Talago, T.A. Meade, E.S. Meade, M.R. Capecchi, E.S. Arnér, and E.E. Schmidt A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification Free Radic. Biol. Med. 63 2013 369 380
38. A.D. Patterson, B.A. Carlson, F. Li, J.A. Bonzo, M.H. Yoo, K.W. Krausz, M. Conrad, C. Chen, F.J. Gonzalez, and D.L. Hatfield Disruption of thioredoxin reductase 1 protects mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity Chem. Res. Toxicol. 26 2013 1088 1096
39. J. Zhang, H. Wang, D. Peng, and E.W. Taylor Further insight into the impact of sodium selenite on selenoenzymes: high-dose selenite enhances hepatic thioredoxin reductase 1 activity as a consequence of liver injury Toxicol. Lett. 176 2008 223 229
40. K. Miyazaki, N. Noda, S. Okada, Y. Hagiwara, M. Miyata, I. Sakurabayashi, N. Yamaguchi, T. Sugimura, M. Terada, and H. Wakasugi Elevated serum level of thioredoxin in patients with hepatocellular carcinoma Biotherapy 11 1998 277 288
41. Y. Kakisaka, T. Nakashima, Y. Sumida, T. Yoh, H. Nakamura, J. Yodoi, and H. Senmaru Elevation of serum thioredoxin levels in patients with type 2 diabetes Horm. Metab. Res. 34 2002 160 1644
42. T. Jikimoto, Y. Nishikubo, M. Koshiba, S. Kanagawa, S. Morinobu, A. Morinobu, R. Saura, K. Mizuno, S. Kondo, S. Toyokuni, H. Nakamura, J. Yodoi, and S. Kumagai Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis Mol. Immunol. 38 2002 765 772
43. S. Tsuchikura, T. Shoji, N. Shimomura, R. Kakiya, M. Emoto, H. Koyama, E. Ishimura, M. Inaba, and Y. Nishizawa Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate BMC Nephrol. 11 2010 7
44. M.E. Callister, A. Burke-Gaffney, G.J. Quinlan, A.G. Nicholson, R. Florio, H. Nakamura, J. Yodoi, and T.W. Evans Extracellular thioredoxin levels are increased in patients with acute lung injury Thorax 61 2006 521 527
45. Y. Yamada, H. Nakamura, T. Adachi, S. Sannohe, H. Oyamada, H. Kayaba, J. Yodoi, and J. Chihara Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma Immunol. Lett. 86 2003 199 205
46. S.K. Leaver, N.S. MacCallum, V. Pingle, M.B. Hacking, G.J. Quinlan, T.W. Evans, and A. Burke-Gaffney Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor Intensive Care Med. 36 2010 336 341
47. S. Ohashi, A. Nishio, H. Nakamura, M. Kido, K. Kiriya, M. Asada, H. Tamaki, T. Fukui, K. Kawasaki, N. Watanabe, J. Yodoi, K. Okazaki, and T. Chiba Clinical significance of serum thioredoxin 1 levels in patients with acute pancreatitis Pancreas 32 2006 264 270
48. A. Abdiu, H. Nakamura, B. Sahaf, J. Yodoi, A. Holmgren, and A. Rosén Thioredoxin blood level increases after severe burn injury Antioxid. Redox Signal. 2 2000 707 716
49. H. Nakamura, S.C. De Rosa, J. Yodoi, A. Holmgren, P. Ghezzi, L.A. Herzenberg, and L.A. Herzenberg Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS Proc. Natl. Acad. Sci. U. S. A. 98 2001 2688 2693
50. S. Miyamoto, T. Sakamoto, H. Soejima, H. Shimomura, I. Kajiwara, S. Kojima, J. Hokamaki, S. Sugiyama, M. Yoshimura, Y. Ozaki, H. Nakamura, J. Yodoi, and H. Ogawa Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction Am. Heart J. 146 2003 465 471
51. J. Hokamaki, H. Kawano, H. Soejima, S. Miyamoto, I. Kajiwara, S. Kojima, T. Sakamoto, S. Sugiyama, M. Yoshimura, H. Nakamura, J. Yodoi, and H. Ogawa Plasma thioredoxin levels in patients with unstable angina Int. J. Cardiol. 99 2005 225 231
52. S. Miyamoto, H. Kawano, T. Sakamoto, H. Soejima, I. Kajiwara, J. Hokamaki, N. Hirai, S. Sugiyama, M. Yoshimura, H. Yasue, H. Nakamura, J. Yodoi, and H. Ogawa Increased plasma levels of thioredoxin in patients with coronary spastic angina Antioxid. Redox Signal. 6 2004 75 80
53. R. Maeda, C. Tabata, R. Tabata, R. Eguchi, Y. Fujimori, and T. Nakano Is serum thioredoxin-1 a useful clinical marker for malignant pleural mesothelioma? Antioxid. Redox Signal. 15 2011 685 689